Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo
$0.0002 0.00 (0.00%)
As of 04/17/2025 09:30 AM Eastern

About Nemaura Medical Stock (NASDAQ:NMRD)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.09
Volume
9,000 shs
Average Volume
11,800 shs
Market Capitalization
$8,070.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

Nemaura Medical Inc (NMRD)
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...
NXNN Nexeon Medsystems Inc
See More Headlines

NMRD Stock Analysis - Frequently Asked Questions

Nemaura Medical's stock was trading at $0.0001 at the beginning of 2025. Since then, NMRD shares have increased by 100.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

Nemaura Medical Inc. (NASDAQ:NMRD) released its quarterly earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter.

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

Last Earnings
2/12/2024
Today
4/20/2025
Next Earnings (Estimated)
4/28/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMRD
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3,017.00
Price / Cash Flow
N/A
Book Value
($0.41) per share
Price / Book
0.00

Miscellaneous

Free Float
24,042,000
Market Cap
$8,070.40
Optionable
No Data
Beta
0.43
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NMRD) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners